Parallax Volatility Advisers’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-40,564
Closed -$7.18M 2983
2020
Q1
$7.18M Buy
40,564
+39,937
+6,370% +$7.52M 0.01% 723
2019
Q4
$120K Sell
627
-4,383
-87% -$791K ﹤0.01% 2101
2019
Q3
$843K Buy
5,010
+875
+21% +$143K ﹤0.01% 1452
2019
Q2
$692K Sell
4,135
-49,007
-92% -$6.79M ﹤0.01% 1411
2019
Q1
$7.78M Buy
53,142
+35,881
+208% +$5.2M 0.01% 546
2018
Q4
$2.31M Sell
17,261
-17,679
-51% -$2.9M ﹤0.01% 1008
2018
Q3
$6.66M Buy
+34,940
New +$6.42M 0.01% 611
2018
Q1
Sell
-7,760
Closed -$1.3M 4986
2017
Q4
$1.27M Buy
7,760
+693
+10% +$124K ﹤0.01% 1096
2017
Q3
$1.45M Buy
+7,067
New +$1.64M ﹤0.01% 942
2016
Q1
Sell
-6,106
Closed -$1.75M 4086
2015
Q4
$1.91M Sell
6,106
-26,032
-81% -$7.75M ﹤0.01% 1027
2015
Q3
$8.73M Buy
+32,138
New +$9.87M 0.02% 497
2015
Q1
Sell
-5,585
Closed -$1.59M 5918
2014
Q4
$1.44M Buy
+5,585
New +$1.4M ﹤0.01% 1266
2014
Q1
Sell
-100
Closed -$17K 3797
2013
Q4
$17K Buy
+100
New +$15.6K ﹤0.01% 2794

Other funds holding AGN

Parallax Volatility Advisers's AGN Position: Q2 2020 in Review

Parallax Volatility Advisers sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 40,564 shares — an estimated $7.18M sold.

Parallax Volatility Advisers first reported a position in AGN in Q4 2013 and held it in 13 quarters. The position peaked at $8.73M in Q3 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Parallax Volatility Advisers reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 40,564 Allergan plc shares in Q2 2020, an estimated $7.18M.
  • Parallax Volatility Advisers first reported a position in Allergan plc in Q4 2013 and held it in 13 quarters.
  • Parallax Volatility Advisers's Allergan plc position peaked at $8.73M in Q3 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Parallax Volatility Advisers's 13F filing for Q2 2020, filed 14 Aug 2020.